Aura Biosciences, Inc.
$7.54+2.03%(+$0.15)
TickerSpark Score
57/100
60
Valuation
20
Profitability
20
Growth
84
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AURA research report →
52-Week Range58% of range
Low $4.73
Current $7.54
High $9.54
Companywww.aurabiosciences.com
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology.
- CEO
- Elisabet de los Pinos
- IPO
- 2021
- Employees
- 106
- HQ
- Boston, MA, US
Price Chart
+27.58% · this period
Valuation
- Market Cap
- $484.07M
- P/E
- -4.52
- P/S
- 0.00
- P/B
- 4.74
- EV/EBITDA
- -3.59
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -78.12%
- ROIC
- -95.48%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-106,191,000 · -22.17%
- EPS
- $-1.76 · -0.57%
- Op Income
- $-112,791,000
- FCF YoY
- -5.10%
Performance & Tape
- 52W High
- $9.54
- 52W Low
- $4.73
- 50D MA
- $7.04
- 200D MA
- $6.22
- Beta
- 0.37
- Avg Volume
- 456.66K
Get TickerSpark's AI analysis on AURA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Start Free Trial →Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 19, 26 | Holles Natalie C. | other | 2,169,103 |
| May 19, 26 | Holles Natalie C. | other | 553,844 |
| May 19, 26 | Holles Natalie C. | other | 600,118 |
| May 7, 26 | Matrix Capital Management Company, LP | sell | 6,922,870 |
| Apr 30, 26 | Holles Natalie C. | other | 0 |
| Apr 16, 26 | Kilroy Conor | sell | 11,738 |
| Mar 2, 26 | Kilroy Conor | other | 62,339 |
| Mar 2, 26 | Kilroy Conor | other | 112,661 |
| Mar 2, 26 | Gibney Anthony S | other | 71,245 |
| Mar 2, 26 | Gibney Anthony S | other | 128,755 |
Our AURA Coverage
We haven't published any research on AURA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AURA Report →